Finance

Lists
INVA:NASDAQ
Innoviva Inc
20,75 USD
-1,47%
(-0,31) 1D
8-окт., 12:43:59 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INVA...
Open
21,05 USD
High
21,05 USD
Low
20,73 USD
Mkt. cap
1,50 млд
Avg. vol.
930,37 миң
Volume
137,21 миң
P/E ratio
5,00
52-wk high
25,14 USD
52-wk low
16,52 USD
EPS
4,15 USD
Beta
0,38
Shares outstanding
72,24 млн
No. of employees
159
Open
21,05 USD
High
21,05 USD
Low
20,73 USD
Mkt. cap
1,50 млд
Avg. vol.
930,37 миң
Volume
137,21 миң
P/E ratio
5,00
52-wk high
25,14 USD
52-wk low
16,52 USD
EPS
4,15 USD
Beta
0,38
Shares outstanding
72,24 млн
No. of employees
159
News stories
From web sources and news partners
About Innoviva Inc
CEO-
Employees159
Founded1996
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteinva.com
Analyst ratings
Based on 4 analysts giving stock ratings to INVA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for INVA in the last 3 months.
Highest
Current 20,75 USD
46,00 USD (+121,69%)
Average
39,25 USD (+89,16%)
Lowest
34,00 USD (+63,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Les Sulewski
Oppenheimer
Buy
Initiated
35,00 USD
+68,7%
09/23/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
35,00 USD
+68,7%
09/23/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
34,00 USD
+63,9%
08/20/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
46,00 USD
+121,7%
08/10/2026
Julian Harrison
BTIG
Buy
Maintained
42,00 USD
+102,4%
08/05/2026
Asad Haider
Goldman Sachs
Sell
Maintained
18,00 USD
-13,3%
05/06/2026
Trevor Allred
Oppenheimer
Buy
Downgraded
35,00 USD
+68,7%
02/26/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
0,56 USD / 0,50 USD
+11,46%beat
Revenue / Est. (USD)
119,59 млн / 110,68 млн
+8,05%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
107,80 млн
114,61 млн
97,99 млн
119,59 млн
Cost of goods sold
35,69 млн
36,18 млн
14,46 млн
21,45 млн
Cost of revenue
35,69 млн
36,18 млн
14,46 млн
21,45 млн
Research and development expenses
-
-
5,24 млн
5,19 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,41 млн
32,08 млн
32,44 млн
34,57 млн
Operating expense
34,03 млн
38,71 млн
44,23 млн
46,39 млн
Total operating expenses
69,72 млн
74,89 млн
58,69 млн
67,84 млн
Operating income
38,08 млн
39,72 млн
39,30 млн
51,76 млн
Other non operating income
-479,00 миң
-612,00 миң
-366,00 миң
-15,00 миң
EBT including unusual items
97,82 млн
195,04 млн
234,56 млн
-108,02 млн
EBT excluding unusual items
39,06 млн
41,95 млн
44,49 млн
53,87 млн
Income tax expense
7,91 млн
30,88 млн
47,97 млн
-24,60 млн
Effective tax rate
8,09%
15,83%
20,45%
22,77%
Other operating expenses
-
-
-
-
Net income
89,91 млн
164,15 млн
186,60 млн
-83,42 млн
Net profit margin
83,40%
143,22%
190,41%
-69,75%
Earnings per share
0,38
0,47
0,47
0,56
Interest and investment income
5,47 млн
6,15 млн
10,99 млн
7,60 млн
Interest expense
-4,02 млн
-3,31 млн
-5,44 млн
-5,47 млн
Net interest expenses
1,46 млн
2,84 млн
5,55 млн
2,13 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
44,73 млн
46,39 млн
45,89 млн
58,45 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору